Published in Schizophr Bull on February 08, 2008
The dopamine hypothesis of schizophrenia: version III--the final common pathway. Schizophr Bull (2009) 6.03
Schizophrenia, "Just the Facts" 6. Moving ahead with the schizophrenia concept: from the elephant to the mouse. Schizophr Res (2011) 5.39
A prospective longitudinal volumetric MRI study of superior temporal gyrus gray matter and amygdala-hippocampal complex in chronic schizophrenia. Schizophr Res (2009) 1.82
Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial. Arch Gen Psychiatry (2010) 1.80
Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies. Schizophr Bull (2011) 1.78
What do we know about neuropsychological aspects of schizophrenia? Neuropsychol Rev (2009) 1.73
Bipolar disorder and mechanisms of action of mood stabilizers. Brain Res Rev (2009) 1.31
The myth of schizophrenia as a progressive brain disease. Schizophr Bull (2012) 1.21
Risperidone administered during asymptomatic period of adolescence prevents the emergence of brain structural pathology and behavioral abnormalities in an animal model of schizophrenia. Schizophr Bull (2010) 1.13
Computational morphometry for detecting changes in brain structure due to development, aging, learning, disease and evolution. Front Neuroinform (2009) 1.13
The lifetime trajectory of schizophrenia and the concept of neurodevelopment. Dialogues Clin Neurosci (2010) 1.08
A framework for interpreting functional networks in schizophrenia. Front Hum Neurosci (2012) 1.05
Genetic associations of brain structural networks in schizophrenia: a preliminary study. Biol Psychiatry (2010) 0.97
Obsessive-Compulsive Disorder, Psychosis, and Bipolarity: A Longitudinal Cohort and Multigenerational Family Study. Schizophr Bull (2014) 0.94
Longitudinal alterations of executive function in non-psychotic adolescents at familial risk for schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.88
A family affair: brain abnormalities in siblings of patients with schizophrenia. Brain (2013) 0.87
Longitudinal progression of frontal and temporal lobe changes in schizophrenia. Schizophr Res (2012) 0.86
Structural brain changes associated with antipsychotic treatment in schizophrenia as revealed by voxel-based morphometric MRI: an activation likelihood estimation meta-analysis. BMC Psychiatry (2013) 0.86
[Not Available]. Open Neuroimag J (2009) 0.83
Continuous kynurenine administration during the prenatal period, but not during adolescence, causes learning and memory deficits in adult rats. Psychopharmacology (Berl) (2014) 0.83
Alterations in brain structures underlying language function in young adults at high familial risk for schizophrenia. Schizophr Res (2012) 0.82
White matter alterations related to P300 abnormalities in individuals at high risk for psychosis: an MRI-EEG study. J Psychiatry Neurosci (2011) 0.82
Elevated levels of kynurenic acid during gestation produce neurochemical, morphological, and cognitive deficits in adulthood: implications for schizophrenia. Neuropharmacology (2014) 0.81
Aging effects on regional brain structural changes in schizophrenia. Schizophr Bull (2011) 0.80
The impact of developmental instability on Voxel-Based Morphometry analyses of neuroanatomical abnormalities in schizophrenia. Schizophr Res (2009) 0.79
Elevated kynurenine pathway metabolism during neurodevelopment: Implications for brain and behavior. Neuropharmacology (2016) 0.79
Prognosis in schizophrenia and the role of subjectivity. Schizophr Bull (2008) 0.78
Cognitive Enhancement Therapy Improves Resting-State Functional Connectivity in Early Course Schizophrenia. J Soc Social Work Res (2016) 0.76
Longitudinal regional brain volume loss in schizophrenia: Relationship to antipsychotic medication and change in social function. Schizophr Res (2015) 0.76
Neuropsychology, autobiographical memory, and hippocampal volume in "younger" and "older" patients with chronic schizophrenia. Front Psychiatry (2015) 0.75
Schizophernia and empty sella - casual or correlated? Pol J Radiol (2011) 0.75
Patterns of regional gray matter loss at different stages of schizophrenia: A multisite, cross-sectional VBM study in first-episode and chronic illness. Neuroimage Clin (2016) 0.75
Progressive deterioration of thalamic nuclei relates to cortical network decline in schizophrenia. Schizophr Res (2016) 0.75
Dynamic endophenotypes and longitudinal trajectories: capturing changing aspects of development in early psychosis. J Psychiatry Neurosci (2016) 0.75
Sluggishness of Early-Stage Face Processing (N170) Is Correlated with Negative and General Psychiatric Symptoms in Schizophrenia. Front Hum Neurosci (2016) 0.75
Current Data on and Clinical Insights into the Treatment of First Episode Nonaffective Psychosis: A Comprehensive Review. Neurol Ther (2016) 0.75
A review of MRI findings in schizophrenia. Schizophr Res (2001) 8.95
Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry (1987) 8.81
Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci (2006) 5.70
Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet (2003) 4.91
Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res (1984) 4.28
Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry (2005) 3.78
Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br J Psychiatry (2006) 3.66
Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proc Natl Acad Sci U S A (2001) 3.45
Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet (1976) 3.14
Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res (1997) 2.49
Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain? Arch Gen Psychiatry (2002) 2.48
Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Arch Gen Psychiatry (2003) 2.39
The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology (2005) 2.37
A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures. Arch Gen Psychiatry (1998) 2.24
Childhood-onset schizophrenia. Progressive ventricular change during adolescence. Arch Gen Psychiatry (1997) 2.15
Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophr Bull (2005) 2.13
Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia. Arch Gen Psychiatry (2007) 2.13
Grey matter changes over time in high risk subjects developing schizophrenia. Neuroimage (2005) 2.09
Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry (2001) 2.02
Lateral cerebral ventricular enlargement in chronic schizophrenia. Arch Gen Psychiatry (1979) 1.94
A controlled study of cortical gray matter and ventricular changes in alcoholic men over a 5-year interval. Arch Gen Psychiatry (1998) 1.93
Longitudinal study of brain morphology in first episode schizophrenia. Biol Psychiatry (2001) 1.86
Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies. Schizophr Res (2005) 1.84
Progressive decrease of left superior temporal gyrus gray matter volume in patients with first-episode schizophrenia. Am J Psychiatry (2003) 1.75
Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biol Psychiatry (1999) 1.73
Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics. Am J Psychiatry (1999) 1.72
Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am J Psychiatry (1994) 1.72
Ventricular enlargement in poor-outcome schizophrenia. Biol Psychiatry (1998) 1.70
Brain volume changes in first-episode schizophrenia: a 1-year follow-up study. Arch Gen Psychiatry (2002) 1.68
Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood. Biol Psychiatry (2007) 1.58
Progressive brain volume loss during adolescence in childhood-onset schizophrenia. Am J Psychiatry (2003) 1.46
Changes in caudate volume with neuroleptic treatment. Lancet (1994) 1.43
Progressive changes of white matter integrity in schizophrenia revealed by diffusion tensor imaging. Psychiatry Res (2007) 1.39
Temporal lobe volume changes in people at high risk of schizophrenia with psychotic symptoms. Br J Psychiatry (2002) 1.38
Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and a proposal concerning the genetic basis of the disease. Arch Gen Psychiatry (1989) 1.38
The intrafamilial environment of schizophrenic patients. II. Marital schism and marital skew. Am J Psychiatry (1957) 1.35
Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia. Am J Psychiatry (2007) 1.33
Normal brain tissue volumes after long-term recovery in anorexia and bulimia nervosa. Biol Psychiatry (2005) 1.32
Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study. Neuropsychopharmacology (2005) 1.32
Progressive grey matter atrophy over the first 2-3 years of illness in first-episode schizophrenia: a tensor-based morphometry study. Neuroimage (2006) 1.31
The timing of brain morphological changes in schizophrenia and their relationship to clinical outcome. Biol Psychiatry (1992) 1.31
Effect of chronic exposure to antipsychotic medication on cell numbers in the parietal cortex of macaque monkeys. Neuropsychopharmacology (2006) 1.20
Neuroimaging and emerging psychotic disorders: the Melbourne ultra-high risk studies. Int Rev Psychiatry (2007) 1.18
Reduction of the parahippocampal gyrus and the hippocampus in patients with chronic schizophrenia. Br J Psychiatry (1999) 1.17
Cerebral ventricular change over the first 10 years after the onset of schizophrenia. Psychiatry Res (2004) 1.17
A longitudinal study of hippocampal volume in first episode psychosis and chronic schizophrenia. Schizophr Res (2001) 1.12
Did schizophrenia exist before the eighteenth century? Compr Psychiatry (1986) 1.11
Progressive loss of cerebellar volume in childhood-onset schizophrenia. Am J Psychiatry (2003) 1.10
Evidence for white matter abnormalities in schizophrenia. Curr Opin Psychiatry (2005) 1.10
Middle and inferior temporal gyrus gray matter volume abnormalities in first-episode schizophrenia: an MRI study. Am J Psychiatry (2006) 1.10
Optimized voxel-based morphometry of gray matter volume in first-episode, antipsychotic-naive schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2005) 1.08
Progressive reduction of temporal lobe structures in childhood-onset schizophrenia. Am J Psychiatry (1998) 1.06
Regional change in brain morphometry in schizophrenia associated with antipsychotic treatment. Psychiatry Res (2006) 1.03
A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients: preliminary findings. Biol Psychiatry (1995) 1.03
An MRI study of basal ganglia volumes in first-episode schizophrenia patients treated with risperidone. Am J Psychiatry (2001) 1.01
An fMRI study of language processing in people at high genetic risk for schizophrenia. Schizophr Res (2007) 0.98
Stability of CT scan findings in schizophrenia: results of an 8 year follow-up study. J Neurol Neurosurg Psychiatry (1988) 0.97
Progression of cerebroventricular enlargement and the subtyping of schizophrenia. Psychiatry Res (1997) 0.96
Association of brain structural change with the heterogeneous course of schizophrenia from early childhood through five years subsequent to a first hospitalization. Psychiatry Res (1998) 0.96
Early detection of schizophrenia by diffusion weighted imaging. Psychiatry Res (2006) 0.95
The effects of antipsychotic treatment on cerebral structure and function in schizophrenia. Int Rev Psychiatry (2007) 0.95
Cerebral ventricular enlargement in schizophrenia. A preliminary follow-up study. Arch Gen Psychiatry (1986) 0.95
Intrafamilial environment of the schizophrenic patient. VI. The transmission of irrationality. AMA Arch Neurol Psychiatry (1958) 0.94
Is schizophrenia a lifetime disorder of brain plasticity, growth and aging? Schizophr Res (1997) 0.93
Fetal brain development and later schizophrenia. Ciba Found Symp (1991) 0.92
Defining the course of brain structural change and plasticity in schizophrenia. Psychiatry Res (1999) 0.91
Ten year progressive ventricular enlargement in schizophrenia: an MRI morphometrical study. Psychiatry Clin Neurosci (2001) 0.91
Evidence for non-progressive changes in adolescent-onset schizophrenia: follow-up magnetic resonance imaging study. Br J Psychiatry (2002) 0.91
Follow up MRI study in first episode schizophrenia. Schizophr Res (1991) 0.90
A serial longitudinal quantitative MRI study of cerebral changes in first-episode schizophrenia using image segmentation and subvoxel registration. Psychiatry Res (2001) 0.87
Failure to find progressive temporal lobe volume decreases 10 years subsequent to a first episode of schizophrenia. Psychiatry Res (2005) 0.86
Pneumoencephalographic evidence of brain atrophy in acute and chronic schizophrenic patients. Acta Psychiatr Scand (1982) 0.85
Effect of clozapine on caudate nucleus volume in relation to symptoms of schizophrenia. Am J Psychiatry (2001) 0.85
Brain morphology in schizophrenia: a 2- to 5-year CT scan follow-up study. Acta Psychiatr Scand (1988) 0.84
Psychotherapy of schizophrenia. Am J Psychiatry (1954) 0.84
Cerebral ventricular enlargement in schizophreniform disorder does not progress. A seven year follow-up study. Schizophr Res (1994) 0.82
Ventricle-to-brain ratio in schizophrenia: a controlled follow-up study. Biol Psychiatry (1989) 0.81
Progressive ventricular enlargement in schizophrenia: comparison to bipolar affective disorder and correlation with clinical course. Biol Psychiatry (1990) 0.81
Brain morphological changes in 1st episode cases of schizophrenia: are they progressive? Schizophr Res (1991) 0.80
Stability of cerebral ventricular size from the appearance of the first psychotic symptoms to the later diagnosis of schizophrenia. Biol Psychiatry (1994) 0.80
Stability of ventricular size after the onset of psychosis in schizophrenia. Psychiatry Res (1991) 0.79
Progressive neurodegeneration after intracerebroventricular kainic acid administration in rats: implications for schizophrenia? Biol Psychiatry (1998) 0.78
The intrafamilial environment of the schizophrenic patient. IV. Parental personalities and family interaction. Am J Orthopsychiatry (1958) 0.76
Basic problems in the psychotherapy of schizophrenia. Psychiatry (1958) 0.76
Premorbid neuropathology in schizophrenia. Lancet (1988) 0.76
Intuitive processes in the psychotherapy of schizophrenics. J Am Psychoanal Assoc (1955) 0.76